- Report
- October 2024
- 185 Pages
Global
From €3234EUR$3,545USD£2,781GBP
€3594EUR$3,939USD£3,090GBP
- Report
- July 2024
- 105 Pages
Global
From €4333EUR$4,750USD£3,727GBP
- Report
- May 2024
- 182 Pages
Global
From €4105EUR$4,500USD£3,531GBP
- Report
- January 2023
- 388 Pages
Global
From €4754EUR$5,393USD£3,950GBP
- Report
- September 2023
- 200 Pages
Global
From €4516EUR$4,950USD£3,884GBP
- Report
- January 2024
- 120 Pages
Global
From €5428EUR$5,950USD£4,668GBP
- Report
- April 2023
- 114 Pages
Global
From €4333EUR$4,750USD£3,727GBP
The Antimicrobial Resistance Surveillance (ARS) market is a subset of the Diagnostics industry, focused on the detection and monitoring of antimicrobial resistance. ARS involves the collection and analysis of data on the prevalence of antimicrobial resistance in a population, as well as the identification of the genetic elements responsible for the resistance. This data is used to inform public health policy and to guide the development of new treatments and strategies to combat antimicrobial resistance. ARS is a rapidly growing market, driven by the increasing prevalence of antimicrobial resistance and the need for better surveillance and monitoring.
Companies in the ARS market include bioMérieux, Becton Dickinson, Cepheid, Hologic, and Roche Diagnostics. Show Less Read more